4
Changes in Ownership
Lyell Immunopharma, Inc. Filed Acc 0001327111-26-000002
President and CEO sold 7,455 shares at $23.39 ($174,372)
From the SEC's structured data for this filing
Trades in this filing
Seely Lynn · President and CEO
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-02-11 | Sale : show line 1 in the form | −7,455 | $23.39 | $174,372 | 74,266 | D |
| Open-market sales · 7,455 sh · avg $23.39 · $174,372 | ||||||
Loading xslF345X05/form4-02132026_010246.xml…